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SCIENTIFIC FOUNDATION

The Effects of Nonvascularized Versus Vascularized Bone
Grafting on Calvarial Defect Healing
Stephanie M. Power, MD, MSc,* Damir B. Matic, MD, MSc,*†‡ and David W. Holdsworth, PhD§||
Abstract: It remains unknown whether bone graft vascularity influences calvarial healing. The purposes of this study were (1) to develop a model to study nonvascularized and vascularized calvarial
grafts as well as (2) to compare effects of bone graft vascularity
on calvarial healing. Bilateral calvarial defects were created in 26
Wistar rats. The defects were left empty within 1 parietal region.
On the contralateral side, the defects were partially closed with native parietal bone (control group, n = 6), nonvascularized (N-V,
n = 10), or vascularized bone grafts (VAS, n = 10). The vascularized
grafts were supplied by perforating dural arterioles. Bone mineralization and healing patterns from serial microcomputed tomographic
scans were compared within and across the groups using parametric
and nonparametric tests. Differences in bone mineral content across
sides were significant between the groups at weeks 6 (P = 0.016)
and 12 (P = 0.025). Bone formation was greater within both the control and VAS groups versus the N-V group at weeks 6 and 12
(P < 0.05). Healing patterns differed between the groups (P < 0.05),
progressing through islands of new bone formation within the control
and VAS groups while limited to defect margins on the N-V graft side.
In conclusion, a bilateral calvarial defect model was established to
study bone graft vascularity. Bone quantity and healing patterns differed in the presence of the nonvascularized versus vascularized grafts.
Although the calvarial defect model is often applied within the plastic
surgery literature to study bone substitutes, greater understanding of
basic mechanisms influencing calvarial healing is first needed to avoid
confounding results.
Key Words: Calvarial defect, bone healing, bone graft,
vascularized, nonvascularized
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C

ranial vault reconstruction may be indicated for patients with
congenital and acquired skull defects. It is clinically relevant
to understand how the skull heals full-thickness defects, both in
adults and in children still undergoing brain growth. For reconstruction of craniosynostosis, segments from the cranial vault are removed, reoriented, and replaced as nonvascularized bone grafts in
a more anatomic three-dimensional shape. Surgeons must expand
the cranial vault and fossae using a finite quantity of bone, which
may leave residual full-thickness defects to spontaneously heal. It
is unknown why certain calvarial defects may close, whereas others
persist or even increase in size (Fig. 1).
Osteogenic properties of the periosteum and dura have been
confirmed.1–8 It remains uncertain whether bone graft vascularity
affects basic mechanisms of dural osteogenesis. Despite this incomplete understanding, the calvarial defect model has been applied
within hundreds of basic science studies in the plastic surgery literature, which may confound results when studying the effectiveness
of various bone substitutes.
The purpose of this study was to develop a model to study
the effects of nonvascularized (N-V) versus vascularized (VAS)
bone grafting on bone production within calvarial defects over time
using microcomputed tomography (micro-CT). Additional objectives were (1) to compare patterns of bone healing between the
groups and (2) to determine whether differences exist over time in
mineralization of N-V versus VAS grafts.

MATERIALS AND METHODS
Ethics approval was granted from the Council on Animal
Care at our local institution (no. 2009-088). Adult male Wistar rats
were randomly assigned to control (n = 6), N-V (n = 10), and VAS
(n = 10) bone graft groups. The animals were 10 weeks of age and
approximately 300 g at the time of surgery.

Operative Technique

Surgeries were performed under isoflurane anesthetic at 2.5
loupe magnification. A 3-cm incision was made through the midline
scalp, extending from the prefrontal to occipital region. Periosteal
flaps were reflected laterally, exposing the denuded parietal bones.
Study design incorporated a bilateral model, providing a defect versus treatment (sham or bone graft) side within each animal.
Calvarial defects and bone grafts were created using a hand-driven
dermal biopsy punch according to surgical group. A dermal punch
was used to decrease potential for thermal injury to bone. Procedures were limited to the parietal bones bilaterally, which excluded
connective tissue of cranial sutures from all calvarial defects and
bone grafts.

Control Group (n = 6)
On the defect side (right parietal bone), a 4-mm calvarial defect was created, in addition to an adjacent full-thickness crescent
defect. On the treatment (sham) side (left parietal), a single 4-mm
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FIGURE 1. Computed tomographic scans of a child's skull after reconstruction
at 1 day (left) and 1 year (right) postoperatively. Several calvarial defects have
spontaneously healed, whereas others (circled) have increased in size in the
parietal region.

calvarial defect was created. Native parietal bone surrounding the
sham defect was not disrupted (Fig. 2A).

N-V Group (n = 10)
Four-millimeter parietal defects were created bilaterally.
Within the left parietal bone (defect side), an adjacent fullthickness crescent defect was also left empty. On the bone graft side
(the right parietal region), N-V bone grafting was performed. The
N-V bone grafts were completely incised along the margins and removed from the cranial vault, therefore disrupting the blood supply
from dural arterioles. The crescent-shaped bone was then irrigated
and returned to the harvest site as an N-V graft (Fig. 2B).

VAS Group (n = 10)
As performed in the N-V group, 4-mm parietal defects were
created bilaterally. An adjacent full-thickness crescent defect was
also made in the left parietal bone (defect side). The bone graft side

Graft Vascularity and Calvarial Healing

(the right parietal region) underwent VAS bone grafting adjacent
to the 4-mm calvarial defect. The VAS bone grafts were completely incised along the margins until ballottable using the tip of the scalpel
blade. They were not removed from the cranial vault however, which
preserved vascularity from underlying dural arterioles (Fig. 2). Vascularity was confirmed through inspection intraoperatively.
Care was taken to avoid injury to the underlying dura and
brain while creating calvarial defects and harvesting bone grafts.
Malleable retractors were positioned to prevent contact between
the dermal biopsy punch and dura at the crescent margin. Saline irrigation was performed intermittently to avoid desiccation of bone
or dura.
Within all groups, two 5′0 polyglactin sutures were secured
between the temporalis muscles across the parietal bones. These sutures stabilized bone grafts in the N-V and VAS groups and
prevented migration. Sutures were similarly placed in the control
group for standardization purposes. The periosteum was then
reapproximated, followed by skin closure.

Imaging Protocol and Analysis
Serial micro-CT scans were performed under isoflurane anesthetic at postoperative weeks 0, 2, 6, and 12 using the SpeCZT
micro-CT scanner (GE Healthcare Biosciences, London, ON,
Canada). The micro-CT scans were analyzed using MicroView software (Version 2.1.2; GE Healthcare Biosciences). Protocol for imaging acquisition and analysis has previously been described.9
Bone analysis was performed to calculate bone mineral content
(BMC) within the calvarial defects and the bone grafts over time.
Bone healing patterns were also recorded, either progressing as
islands of new bone formation or limited to defect margins. Regions
of interest (ROIs) were selected on baseline micro-CT scans and
applied to coregistered scans over time (Figs. 3A, B).

Statistical Analysis
Statistical analysis was performed using SPSS software, version 17 (IBM, Somers, NY). Within the groups, BMC was compared between defect and treatment (sham or bone graft) sides at
each time point using paired t-tests. Differences in BMC between
treatment and defect (T-D) sides were compared between the groups
using 1-way analysis of variance (ANOVA) at each time point. If a
difference was found using ANOVA, post hoc comparisons were
performed using the Tukey honestly significant difference t-test to
identify the difference between pairs. Nonparametric analysis was

FIGURE 2. A, Control group (n = 6). The intraoperative photograph on the left
shows a bird's-eye view of the rat skull. Anterior and posterior references are
marked. Bilateral calvarial defects were created in the parietal bones. Dura
and dural arterioles are visible at the base of the full-thickness defects. The
schematic diagram corresponds to the intraoperative photograph. (4 mm
indicates full-thickness calvarial defect with 4-mm diameter; def, full-thickness
crescentic defect). B, The N-V and VAS groups showing defect and bone
graft sides within the left and right parietal bones, respectively. Anterior and
posterior references are marked. (4 mm indicates full-thickness calvarial
defect with 4-mm diameter; def, full-thickness crescentic defect.)

FIGURE 3. A, Example of cylindrical ROI created within a calvarial defect
(bird’s-eye and oblique views on left and right, respectively). B, Example of
crescentic ROI created using spline tool in MicroView.
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TABLE 2. Nonparametric Analysis Within Groups
Group

Week 2

Week 6

Week 12

Control

0.917
0.508
0.074

0.028*
0.169
0.028*

0.028*
0.333
0.037*

N-V
VAS

Wilcoxon 2-sample tests comparing BMC of treatment (sham or bone graft) versus
defect sides within the groups over time.
*Significance, P < 0.05.

between the groups for empty, N-V, and VAS crescents. Intrarater reliability demonstrated an intraclass correlation coefficient of 0.928.

FIGURE 4. A, The BMC of sham versus defect sides for the control group.
The BMC expressed in milligrams. Asterisk indicates P = 0.042. B, The BMC
of bone graft versus defect sides for the N-V group. The BMC expressed
in milligrams. C, The BMC of bone graft versus defect sides for the VAS group.
The BMC expressed in milligrams. Asterisk indicates P = 0.032; double asterisk,
P = 0.024. Error bars represent SEM.

used to support findings from parametric tests due to small sample
sizes. The Kruskal-Wallis and Wilcoxon 2-sample tests were applied for 3- and 2-group comparisons, respectively.
The BMCs of posterior crescents on the N-V versus VAS
bone graft sides were compared using unpaired t-tests at each time
point. Differences between T-D posterior crescents were also compared between the groups over time using unpaired t-tests. Crescent
volume was compared between the groups using ANOVA to determine whether significant differences existed in the size of empty,
N-V, and VAS bone graft crescents.
The McNemar test was applied within the groups to compare
patterns of bone formation between the sides. The Fisher exact test
was used to compare healing patterns between the groups.
Fourteen randomly selected CT scans were measured on 3
different days to calculate intrarater reliability.10 Repeat BMC measurements were compared using intraclass correlation coefficients.

Bone Mineral Content: Treatment Versus
Defect Sides Within the Groups
The control group demonstrated greater BMC on the sham
versus defect side at week 12 (P = 0.042; Fig. 4A, Tables 1 and 2).
No differences existed in the BMC on the sham versus defect sides
within the control group at other time points.
Within the N-V group, the BMC between the sides was not statistically different over time (Fig. 4B, Tables 1 and 2). Greater BMC
was seen within the VAS group on the bone graft versus defect side
at weeks 6 (P = 0.032) and 12 (P = 0.024; Fig. 4C, Tables 1 and 2).

Bone Mineral Content: Treatment Minus Defect
Sides Between the Groups
Differences in BMC between treatment (sham or bone
graft) and defect (T-D) sides for all groups over time are shown in
Figure 5. The T-D differences were significant between the groups
at weeks 6 (P = 0.016) and 12 (P = 0.025; Table 3). At week 6,
the T-D difference was greater for the control versus the N-V group
(P = 0.043; Table 4). The T-D difference was also greater for the
VAS versus N-V group (P = 0.030). No differences were seen between the control and VAS groups (P = 0.978) at week 6. At week
12, T-D differences were also greater for the control and VAS versus
N-V groups (P = 0.038 and 0.050, respectively). The control and
VAS groups did not show any differences (P = 0.817).

RESULTS
Surgeries were performed on 26 male Wistar rats (6 controls,
10 per bone graft group). Intraoperatively, the VAS bone grafts
demonstrated a pink cast similar to adjacent bone, which suggested
that vascularity was preserved from perforating dural arterioles. In
contrast, the N-V bone grafts appeared white. No postoperative complications were encountered. Micro-CT scans taken at week 0 did not
reveal any subdural or epidural collections or pneumocephalus.
Conclusions from parametric tests were confirmed using the
nonparametric analysis. The P values within this section refer to the
parametric analysis. No differences in ROI volume were seen

Bone Mineral Content: Posterior Crescents in
the N-V Versus VAS Groups
At week 2, BMC was higher for posterior crescents in the VAS
versus N-V groups on the bone graft side (P = 0.007, Table 5). No differences in the posterior crescent BMC were seen between the N-V
and VAS groups at week 6 or 12 (P = 0.386 and 0.645, respectively).

TABLE 1. Parametric Analysis Within Groups
Group

Week 2

Week 6

Week 12

Control

0.550
0.597
0.079

0.091
0.193
0.032*

0.042*
0.427
0.024*

N-V
VAS

Paired t-tests comparing BMC of treatment (sham or bone graft) versus defect sides
within the groups over time.
*Significance, P < 0.05.
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FIGURE 5. The BMC differences for treatment minus defect (T-D) sides within
the groups over time. The BMC expressed in milligrams. Error bars represent
SEM. Asterisk indicates P = 0.016; double asterisk, P = 0.025.
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TABLE 3. BMC Differences Between Groups
Week
0

ANOVA

TABLE 5. Analysis of Graft BMC Over Time: VAS versus N-V
Kruskal-Wallis

P = 0.515
0.278
0.016*
0.025*

2
6
12

Graft Vascularity and Calvarial Healing

0.869
0.140
0.046*
0.077

Statistical comparisons of BMC differences for treatment minus defect (T-D) sides
between the groups.

Comparison
t-test
Wilcoxon

Week 0

Week 2

Week 6

Week 12

0.117
0.123

0.007*
0.009*

0.386
0.529

0.645
0.796

Statistical comparisons for posterior crescents on the treatment side between N-V
and VAS over time.
*Significance, P < 0.05.
t-Test, unpaired t-tests. Wilcoxon, Wilcoxon 2-sample tests.

*Significance, P < 0.05.

The BMC differences for treatment minus defect (T-D) posterior crescents for the N-V and VAS groups over time are shown
in Figure 6. The T-D posterior crescent differences were greater
within the VAS versus N-V group at week 2 (P = 0.050; Table 6).
Differences for T-D posterior crescents were no longer significant
between the N-V and VAS groups at week 6 (P = 0.423) or 12
(P = 0.467).

Patterns of Bone Formation
Bone healing patterns for defect and treatment (sham or bone
graft) sides within the groups are included in Figures 7A and B, respectively. In the control group, healing progressed through islands
of bone formation within 50% of defect sides and the majority
(83.3%) of sham sides. Most defect sides (70%) in the N-V group
healed through islands of new bone. The N-V bone graft sides,
however, healed primarily from bone margins (70%). In the VAS
group, bone healing occurred through islands of bone formation
within the majority of defect (70%) and treatment (80%) sides.
Within the groups, bone healing patterns were not statistically
different between the sides (control, P = 0.500; N-V, P = 0.289;
VAS, P = 1.000). Across the group, comparisons did not show healing
pattern differences on the defect side (P = 0.758). Healing patterns on
the treatment (sham or bone graft) side were different, however, between the control, N-V, and VAS groups (P = 0.047). In the control
and VAS groups, healing occurred mostly as islands of new bone formation when framed by VAS bone (Figs. 7C and D, respectively).
When partially filled with N-V bone grafts, healing occurred mostly
at defect margins in the N-V group (Fig. 7E).

DISCUSSION
Previous research on calvarial defect healing has largely focused on the effectiveness of scaffolds and bone substitutes.11–20
Further studies have evaluated the osteogenic potential of local factors within bone graft recipient sites, including the dura, periosteum, and adjacent bone. The dura is believed to be the dominant
factor promoting revascularization and bone healing.4,21 Limited
osteogenic and angiogenic properties have been shown for adjacent
bone when bone graft healing is isolated from the dura and

periosteum.4 The dura is theorized to be actively osteogenic as well
as promoting adjacent calvarial marrow to form bone through production of growth factors.4,21 Recipient sites in these studies
contained N-V bone grafts, which provided an acellular scaffold
for bone healing.4,21
Cranial vault surgery may incorporate both N-V and VAS
bone segments during reconstruction. The effects of bone graft vascularity on basic mechanisms of calvarial healing remain unknown.
The calvarial defect model established within this study maintained
intact dura at the calvarial defect base and reapproximated the periosteum. Surgical technique created calvarial defects and bone grafts
using a hand-driven dermal biopsy punch to minimize potential for
thermal injury to bone.22 Powered instruments may lead to detrimental effects on the dura, blood vessels, and adjacent bone through
heat production, which may confound results.23
Surgical groups differed only with respect to the adjacent
bone crescent on the sham or bone graft side, including native parietal bone, N-V, or VAS bone graft. Pericranial vessels were disrupted
in all groups during parietal bone exposure. In the control group, the
adjacent crescent was supplied by the arterial network within the parietal bone, in addition to perforating arterioles from the dura. The VAS
bone grafts were supplied by perforating dural arterioles. For the N-V
bone grafts, the parietal bone arterial plexus, dural, and pericranial
vessels had all been disrupted.
Findings suggest that bone graft vascularity may significantly affect the quantity of bone production during calvarial
healing. At weeks 6 and 12, healing was impaired on the N-V bone
graft side versus the VAS and sham sides. Calvarial healing was not
statistically different in the presence of native parietal bone versus
VAS bone grafts. Nonvascularized bone grafts may initiate greater
osteoclastic activity, which may decrease overall bone production
during calvarial healing. An alternative theory is that dural osteogenesis may be inhibited by local release of intracellular contents after osteocyte death in N-V bone grafts. Revascularization
of N-V grafts may be incomplete, which may make delivery of
dural growth factors less efficient as well as result in fewer endothelial cells to stimulate.

TABLE 4. Post Hoc Analysis of BMC Differences Using 2-Group Comparisons
Group Comparisons

Week 6

Week 12

Control vs N-V

0.043*
0.978
0.030*

0.038*
0.817
0.050*

Control vs VAS
N-V vs VAS

Post hoc Tukey honestly significant difference test to identify differences between
the 2-group comparisons after 1-way ANOVA.
*Significance, P < 0.05.

FIGURE 6. The BMC differences for posterior crescents on treatment (bone
graft) minus defect (T-D) sides for the N-V and VAS groups over time. The BMC
differences expressed in milligrams. Error bars represent SEM. Asterisk indicates
P = 0.050.
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TABLE 6. BMC Differences Between Sides Across Groups: VAS versus N-V
Comparison
t-test
Wilcoxon

Week 0

Week 2

Week 6

Week 12

0.072
0.052

0.050*
0.063

0.423
0.529

0.467
0.529

Comparisons of BMC differences in posterior crescents on treatment minus defect
(T-D) sides between N-V and VAS over time.
*Significance, P < 0.05.
t-Test, unpaired t-tests. Wilcoxon, Wilcoxon 2-sample tests.

Patterns of Calvarial Healing
Heine (1926) observed that calvarial defect healing
progressed from both the native bone edges and bone islands originating from dura mater.24 Dural osteogenesis is the dominant
mechanism of calvarial healing, and bone formation decreases significantly in its absence.25,26 Bone healing progressed through
islands of new bone formation within the majority of defect and
treatment sides in the control and VAS groups in the presence of
either native parietal bone or VAS bone grafts. In contrast, healing
occurred primarily from bone margins on the N-V bone graft side.
The majority of previous studies noted progression of
calvarial healing from defect margins. Gurevitch et al27 observed
healing from bone margins within calvarial defects filled with
demineralized bone matrix. When fibrin glue was added, containing
fibrinogen and thrombin, which are involved in the coagulation cascade, healing occurred as islands of new bone formation. Differences in healing patterns within previous studies may be attributed
to the presence of inert scaffolds, as seen in the N-V group within
this study.27–34 Sampling error of histologic preparations may be a
confounding variable, however, in some cases. Histologic examinations are limited to two-dimensional slices, which may fail to identify small islands of bone formation. Bone islands were identified
within this study using micro-CT, which provided high-resolution
nondestructive imaging of three-dimensional bone architecture.
Bone graft vascularity may alter basic mechanisms of calvarial
healing. Findings from this study suggest that a feedback loop may exist during calvarial healing, which determines whether appositional,
dural, or pericranial osteogenesis is the dominant mechanism. In the
presence of N-V bone grafts, healing was limited to defect margins
and seemed to inhibit dural osteogenesis. Nonvascularized grafts
may shift the balance toward greater osteoclastic versus osteoblastic
activity. Remodeling and revascularization of N-V bone grafts may
become the dominant process, making dural osteogenesis less efficient for repair of residual calvarial defects. Marginal healing seemed
to progress through appositional bone growth.
Interestingly, calvarial healing was not statistically different
between the defect versus bone graft sides within the N-V group.
No differences in BMC were seen over time within the defects partially closed with N-V bone graft versus those left empty, leaving an
initial bone defect of larger surface area. The N-V bone graft crescents demonstrated greater BMC over time as compared with empty
crescents and may provide a scaffold for calvarial healing. Although
the N-V grafts resulted in greater healing at defect margins, they did
not promote bone production within central defects.

Calvarial Bone Graft Healing and Vascularity
Fukuta et al35 found greater resorption of N-V versus VAS
bone grafts when placed as onlay grafts in the temporal fossa using
water displacement measurements. The VAS bone grafts were supplied by pericranial vessels in contrast to the dural arteriolar supply
to the VAS grafts within this study. Normal bone architecture was
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seen on histologic examination of VAS bone grafts at 12 weeks in
comparison with fibrous tissue ingrowth within N-V grafts.35 Cutting and McCarthy36 similarly found less resorption of VAS versus
N-V onlay bone grafts in composite myo-osseous flaps assessed by
bone sample weights.
Micro-CT permitted precise quantification of BMC within
bone grafts over time within this study. No significant resorption
occurred for either N-V or VAS bone grafts placed as inlay grafts
within parietal defects. The VAS bone grafts demonstrated greater
BMC than the N-V grafts did at 2 weeks postoperatively, which
may suggest that vascularity plays a role in early bone graft healing.
Previous studies have shown acellular marrow and empty lacunae in
early N-V bone graft healing compared with osteocytes and cellular
marrow within VAS grafts.37 Our results did not show any differences in BMC between the N-V and VAS bone grafts as healing
progressed through 6 and 12 weeks postoperatively. The N-V bone
grafts, although acellular, may provide a scaffold for early bone
healing and ingrowth of blood vessels.
Effects of radiation on calvarial defect healing within this
study remain unknown. The imaging protocol at our center has been
optimized at approximately 30 cGy per acquisition to minimize radiation exposure while maintaining adequate resolution to study
bone microarchitecture.38 All rats were subject to an equivalent cumulative dose. Both VAS and N-V bone grafts may potentially be
affected by high-dose irradiation because of direct damage to
microvessels and disruption of angiogenesis.39,40
Although VAS bone grafting was associated with enhanced
dural osteogenesis, the mechanism of action was not proven by this
study design. Biomolecular and histologic studies will be performed
to measure osteoclastic versus osteoblastic activity to further understand mechanisms regulating dural osteogenesis.
In conclusion, a bilateral defect model was established to
study the effects of N-V versus VAS bone grafting on calvarial
healing. Greater bone production occurred within native parietal
bone and VAS bone grafts at later stages, and dural regeneration
seemed to be primarily responsible for calvarial healing. The N-V
bone graft healing was restricted to defect margins. Greater understanding of the effects of calvarial vascularity on bone healing is
needed before further application of the calvarial defect model
within basic science studies.

FIGURE 7. A, Patterns of bone formation on the defect side by group.
B, Patterns of bone formation on the treatment (sham or bone graft) side by
group. Difference between the groups in healing patterns on the treatment
side is shown using ANOVA. Asterisk indicates P = 0.047. C, Representative
isosurface image for a control rat at week 12, showing healing through new
bone islands on the sham (animal's left) side. D, Representative isosurface image
for a VAS rat at week 12, showing healing primarily through islands of new
bone formation on the bone graft (animal's right) side. E, Representative
isosurface image for an N-V rat at week 12, showing marginal healing on
the bone graft (animal's right) side.
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